Please visit our MS learning channel on YouTube, which provides hundreds of MS related topics from many of our video recorded education programs and archived here: -- Be empowered with MS views and news. Opt-in with us:

~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Thursday, February 11, 2016

Microsoft and Novartis Team Up to Tackle Multiple Sclerosis

Microsoft Novartis Kinect MS
Microsoft and Novartis are joining forces against multiple sclerosis (MS), the autoimmune disease that affects millions of people worldwide.
Using Microsoft’s Kinect, they have developed a tool called Assess MS that can monitor and evaluate a patient’s movements to determine if the disease is progressing or not—quantifying a patient’s status has been a top challenge with MS.
Microsoft Novartis Kinect MS
When Microsoft released the Kinect system for playing Xbox video games about five years ago, little did it know it would be parenting with a healthcare company. For years, Novartis has been trying to find more consistent ways to quantify whether the treatments it is developing for multiple sclerosis are working, but assessing whether a patient’s symptoms are stabilizing or getting worse is complicated.
Learn more

MS Views and News 
helps to provide educational information for persons affected by MS
Keep current with Multiple Sclerosis news and information 
by opting-in to our website: click here - thank you

No comments: